在那些在怀孕早期首次出现抑郁症的人中,神经活性类固醇水平升高
Elizabeth S Wenzel1,2, Jordan C Barone3, Tory A Eisenlohr-Moul3
1Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, United States.
Frontiers in psychiatry
|May 23, 2025
概括
神经活性类固醇 (NAS) 含量,包括全孕 (ALLO),在患有围产期抑郁症 (PND) 的女性中因她们有重大抑郁症 (MDD) 史而有所不同. 这些发现凸显了PND病原体中与NAS相关的独特机制.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 精神病学是一个精神病学.
- 内分泌学 在内分泌学.
背景情况:
- 阿洛普雷格纳诺 (ALLO) 涉及产后抑郁症 (PND) 的致病性.
- 在怀孕期间ALLO和抑郁症之间的关联是不一致的.
- 怀孕前严重抑郁症 (MDD) 史和PND时间对神经活性类固醇 (NAS) 水平的影响尚不清楚.
研究的目的:
- 调查第一 (T1) 和第二 (T2) 季度ALLO和其他NAS水平的差异.
- 根据怀孕前的MDD史和当前的PND状态来比较NAS水平.
主要方法:
- 量化ALLO,孕 (PA),异孕 (ISO),孕 (EPI) 和孕激素 (P4),使用气色谱-质谱法.
- 将98名参与者 (T1) 和93名参与者 (T2) 分为:从未患过抑郁症,怀孕前抑郁症,复发性抑郁症和围产期出现的抑郁症组.
- 利用协同变量的分析与对对比来评估跨组的NAS水平.
主要成果:
- T1 ALLO和ISO水平在各组之间显示出显著差异,围产期出现抑郁症组的水平更高.
- 在T2中,PA水平显著不同,ALLO和ISO水平显示出边际差异.
- 与其他组相比,在围产期出现的抑郁症组中观察到ALLO,PA和ISO升高的特定模式.
结论:
- 研究结果表明,在PND临床表型中,与NAS相关的病原机制是不同的.
- 怀孕前的MDD史和PND发病时间是影响NAS关联的关键因素.
- 未来对NAS和PND的研究应该纳入这些临床区别.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
382
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
382
Antidepressant Drugs: Overview
805
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
805
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
631
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
631
Depression: Overview
377
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
377
Depressive Disorders: Etiology
173
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
173


